ZFIN Image: Benato et al., 2014, Fig. 6

Image

Figure Caption

Fig. 6

Reduced GRE activity following treatment with the GR antagonist RU486. Two-dpf transgenic embryos were treated for 24 h with 10 µM DEX alone or combined with three different RU486 concentrations (50, 250 and 1250 nM). Left panel: fold changes in gene expression of fkbp5 and egfp in treated embryos as compared to only DEX-treated control (set at 1). The expression levels of the target genes were normalized on ef1a as housekeeping gene. Values represent the mean ± S.E. Asterisks indicate expression levels that are significantly different from control (DEX-treated ia20): *P < 0.05; **P < 0.01; ***P < 0.001. Right panel: WMISH of egfp mRNA after DEX treatment alone or combined with RU486 at different concentrations. Scale bar: 200 µM.

Figure Data

Expression / Labeling details

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image.

Reprinted from Molecular and Cellular Endocrinology, 392(1-2), Benato, F., Colletti, E., Skobo, T., Moro, E., Colombo, L., Argenton, F., Dalla Valle, L., A living biosensor model to dynamically trace glucocorticoid transcriptional activity during development and adult life in zebrafish, 60-72, Copyright (2014) with permission from Elsevier. Full text @ Mol. Cell. Endocrinol.